Ep135: John Maraganore on Developing a New Class of Medicines
John Maraganore, former founding CEO of Alnylam P…
The Long Run with Luke Timmerman · Timmerman Report
May 8, 20231h 3m
Audio is streamed directly from the publisher (feeds.soundcloud.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
John Maraganore, former founding CEO of Alnylam Pharmaceuticals, on his life in biotech and developing RNA interference as a new class of medicine.